Showing results (191-200 of 237) with videos related to
Sort By:
Pageof 24
Cerebral Cortex (New York, N.Y. : 1991)|January 26, 2024
Utility of cortical tissue analysis in normal pressure hydrocephalusAna B W Greenberg, Kedous Y Mekbib, Neel H Mehta, et al.Science (New York, N.Y.)|June 14, 2014
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastomaAnoop P Patel, Itay Tirosh, John J Trombetta, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2026
Dose Escalation With Intensity-Modulated Proton Therapy for Patients with High-Risk Meningiomas - Results From a Phase 1 TrialFelix Ehret, Nora K Horick, Beow Y Yeap, et al.Cancer|January 15, 2015
Proton therapy for low-grade gliomas: Results from a prospective trialHelen A Shih, Janet C Sherman, Lisa B Nachtigall, et al.The Oncologist|October 31, 2018
Enrichment of HER2 Amplification in Brain Metastases from Primary Gastrointestinal MalignanciesDevarati Mitra, Jeffrey W Clark, Helen A Shih, et al.Toxicology|April 22, 2008
Integration of in vivo and in vitro approaches to characterize the toxicity of Antalarmin, a corticotropin-releasing hormone receptor antagonistThomas L Horn, J Brooks Harder, William D Johnson, et al.Journal of Neurosurgery|January 22, 2026
Protocol for the systematic reduction of sterile surgical instrument waste: a single-institution prospective implementation and analysisTimothy R West, Nicole A Perez, Kwaku Adubofour, et al.Journal for Immunotherapy of Cancer|November 16, 2019
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastomaBryan D Choi, Xiaoling Yu, Ana P Castano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2020
TERT Promoter Mutation Analysis for Blood-Based Diagnosis and Monitoring of GliomasKoushik Muralidharan, Anudeep Yekula, Julia L Small, et al.World Neurosurgery|October 13, 2019
Atypical Histopathological Features and the Risk of Treatment Failure in Nonmalignant Meningiomas: A Multi-Institutional AnalysisNayan Lamba, William L Hwang, Daniel W Kim, et al.Pageof 24